Universitätsklinikum Heidelberg
wanted for the next possible date in the research group of Dr. Michael Hoetker.
The Hoetker lab at the University Hospital Heidelberg focuses on the corruption of cellular identity in diffuse large B cell lymphoma (DLBCL). We aim to decode epigenetic principles of disease, in particular targeting enhancers and other regulatory elements. The final aim of our studies is to translate the experimental findings into novel treatment strategies for patients at diagnosis and relapse.
For further information please contact Dr. Michael Hoetker via e-mail michael.hoetker@med.uni-heidelberg.de or phone.
Interested?
We are looking forward to receiving your application.
Note: The UKHD is subject to the provisions of the Infektionsschutzgesetz. Therefore, a valid measles immunity certificate is required for all persons employed at the UKHD.
The UKHD embraces diversity and values diversity.
Regardless of age, gender, sexual identity, disability, origin or religion, we offer everyone the same opportunities. I
Postdoctoral Research Associate (d/f/m) Berlin-Buch Vollzeit Max-Delbrück-Centrum für Molekulare Medizin PhD/Postdoctoral Researcher (m/f/d). Multi-Domain Computational Modeling of the Neuromuscular System for the Human Digital Twin München Vollzeit Technische Universität München ostdoc Position in Membrane Protein Structural Biology München Vollzeit Technische Universität München
Postdoc Group Gekara Freiburg Vollzeit Universitätsklinikum Freiburg Doktorandenstelle (d/m/w) Thema: Stoffumsatz im Verlauf mikrobieller Sukzession Halle (Saale) Vollzeit Helmholtz-Zentrum für Umweltforschung UFZ